UB Paderborn / Katalog / Suche / in CDI

1 – 19 von 19

Sortiert nach

Ethnic differences in the population pharmacokinetics and pharmacodynamics of warfarin

Journal of pharmacokinetics and pharmacodynamics, 2010-02, Vol.37 (1), p.3-24

2010

Link zum Volltext

Verfügbarkeit prüfen

Donanemab Population Pharmacokinetics, Amyloid Plaque Reduction, and Safety in Participants with Alzheimer's Disease

Clinical pharmacology and therapeutics, 2023-06, Vol.113 (6), p.1258-1267

2023

Link zum Volltext

Verfügbarkeit prüfen

Donanemab exposure‐efficacy relationship in patients with early symptomatic Alzheimer’s disease

Alzheimer's & dementia, 2023-06, Vol.19 (S7), p.n/a

2023

Link zum Volltext

Verfügbarkeit prüfen

Disease progression model using the integrated Alzheimer's Disease Rating Scale

Alzheimer's & dementia, 2023-06, Vol.19 (6), p.2253-2264

2023

Link zum Volltext

Verfügbarkeit prüfen

Early change in tumour size predicts overall survival in patients with first-line metastatic breast cancer

European journal of cancer (1990), 2016-10, Vol.66, p.95-103

2016

Link zum Volltext

Verfügbarkeit prüfen

Handling Missing Data in a Duloxetine Population Pharmacokinetic/Pharmacodynamic Model – Imputation Methods and Selection Models

Pharmaceutical research, 2014-10, Vol.31 (10), p.2829-2843

2014

Link zum Volltext

Verfügbarkeit prüfen

Amyloid re‐accumulation after donanemab treatment: summary from 3 interventional trials

Alzheimer's & dementia, 2023-12, Vol.19 (S14), p.n/a

2023

Link zum Volltext

Verfügbarkeit prüfen

Fuzzy simulation of pharmacokinetic models: Case study of whole body physiologically based model of diazepam

Journal of pharmacokinetics and pharmacodynamics, 2004-06, Vol.31 (3), p.185-213

2004

Link zum Volltext

Verfügbarkeit prüfen

A phase 1 study of anti-TGFβ receptor type-II monoclonal antibody LY3022859 in patients with advanced solid tumors

Cancer chemotherapy and pharmacology, 2017-04, Vol.79 (4), p.673-680

2017

Link zum Volltext

Verfügbarkeit prüfen

Disposition and metabolism of [14C]-galunisertib, a TGF-βRI kinase/ALK5 inhibitor, following oral administration in healthy subjects and mechanistic prediction of the effect of itraconazole on galunisertib pharmacokinetics

Xenobiotica, 2018-04, Vol.48 (4), p.382-399

2018

Link zum Volltext

Verfügbarkeit prüfen

Cardiac Safety of TGF-β Receptor I Kinase Inhibitor LY2157299 Monohydrate in Cancer Patients in a First-in-Human Dose Study

Cardiovascular toxicology, 2015-10, Vol.15 (4), p.309-323

2015

Link zum Volltext

Verfügbarkeit prüfen

Population pharmacokinetic modelling of S-warfarin to evaluate the design of drug–drug interaction studies for CYP2C9

Journal of pharmacokinetics and pharmacodynamics, 2012-04, Vol.39 (2), p.147-160

2012

Link zum Volltext

Verfügbarkeit prüfen

A phase 1 study of anti-TGF[beta] receptor type-II monoclonal antibody LY3022859 in patients with advanced solid tumors

Cancer chemotherapy and pharmacology, 2017-04, Vol.79 (4), p.673

2017

Link zum Volltext

Verfügbarkeit prüfen

Linking preclinical and clinical whole-body physiologically based pharmacokinetic models with prior distributions in NONMEM

European journal of clinical pharmacology, 2007-05, Vol.63 (5), p.485-498

2007

Link zum Volltext

Verfügbarkeit prüfen

Diazepam pharamacokinetics from preclinical to phase I using a bayesian population physiologically based pharmacokinetic model with informative prior distributions in winbugs

Journal of pharmacokinetics and pharmacodynamics, 2006-10, Vol.33 (5), p.571-594

2006

Link zum Volltext

Verfügbarkeit prüfen

Cardiac Safety of TGF-[beta] Receptor I Kinase Inhibitor LY2157299 Monohydrate in Cancer Patients in a First-in-Human Dose Study

Cardiovascular toxicology, 2015-10, Vol.15 (4), p.309

2015

Link zum Volltext

Verfügbarkeit prüfen

Reducing whole body physiologically based pharmacokinetic models using global sensitivity analysis : diazepam case study

Journal of pharmacokinetics and pharmacodynamics, 2006-02, Vol.33 (1), p.1-27

2006

Link zum Volltext

Verfügbarkeit prüfen

A comment on the "correction" of tissue-plasma partition coefficients for drug extraction in eliminating organs by Sven Björkman

Journal of pharmacokinetics and pharmacodynamics, 2005-12, Vol.32 (5-6), p.659-662

2005

Link zum Volltext

Verfügbarkeit prüfen

Uncertainty analysis of pharmacokinetic/pharmacodynamic models

Gueorguieva, Ivelina

2002

Link zum Volltext
ProQuest

1 – 19 von 19

Suche als RSS-Feed

Aktive Filter

KollektionEZB Electronic Journals Library

ThemaPharmacokinetics

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(18)
Mit Volltextzugriff
(17)

Publikationsform

Artikel
(18)
Dissertationen
(1)

Sprache

Englisch
(19)
Japanisch
(1)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Ethnic differences in the population pharmacokinetics and pharmacodynamics of warfarin

Donanemab Population Pharmacokinetics, Amyloid Plaque Reduction, and Safety in Participants with Alzheimer's Disease

Donanemab exposure‐efficacy relationship in patients with early symptomatic Alzheimer’s disease

Disease progression model using the integrated Alzheimer's Disease Rating Scale

Early change in tumour size predicts overall survival in patients with first-line metastatic breast cancer

Handling Missing Data in a Duloxetine Population Pharmacokinetic/Pharmacodynamic Model – Imputation Methods and Selection Models

Amyloid re‐accumulation after donanemab treatment: summary from 3 interventional trials

Fuzzy simulation of pharmacokinetic models: Case study of whole body physiologically based model of diazepam

A phase 1 study of anti-TGFβ receptor type-II monoclonal antibody LY3022859 in patients with advanced solid tumors

Disposition and metabolism of [14C]-galunisertib, a TGF-βRI kinase/ALK5 inhibitor, following oral administration in healthy subjects and mechanistic prediction of the effect of itraconazole on galunisertib pharmacokinetics

Cardiac Safety of TGF-β Receptor I Kinase Inhibitor LY2157299 Monohydrate in Cancer Patients in a First-in-Human Dose Study

Population pharmacokinetic modelling of S-warfarin to evaluate the design of drug–drug interaction studies for CYP2C9

A phase 1 study of anti-TGF[beta] receptor type-II monoclonal antibody LY3022859 in patients with advanced solid tumors

Linking preclinical and clinical whole-body physiologically based pharmacokinetic models with prior distributions in NONMEM

Diazepam pharamacokinetics from preclinical to phase I using a bayesian population physiologically based pharmacokinetic model with informative prior distributions in winbugs

Cardiac Safety of TGF-[beta] Receptor I Kinase Inhibitor LY2157299 Monohydrate in Cancer Patients in a First-in-Human Dose Study

Reducing whole body physiologically based pharmacokinetic models using global sensitivity analysis : diazepam case study

A comment on the "correction" of tissue-plasma partition coefficients for drug extraction in eliminating organs by Sven Björkman

Uncertainty analysis of pharmacokinetic/pharmacodynamic models

Aktive Filter

Suchergebnisse filtern